Operating CF
$9.46B
Capex
-$2.09B
Free Cash Flow
$7.38B
FCF Margin
+78.0%
Cash flow waterfall for Abbott Laboratories (ABT) — TTM through Q1 2026
Free cash flow: $7.38B
Cash flow breakdown for Abbott Laboratories (ABT) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Operating Cash Flow | $9.46B | $9.46B |
| Capital Expenditure | -$2.09B | $7.38B |
| Free Cash Flow | $7.38B | $7.38B |
| Acquisitions | -$19.9B | -$12.5B |
| Other Investing | -$287M | -$12.8B |
| Share Buybacks | -$793M | -$13.6B |
| Dividends Paid | -$4.19B | -$17.8B |
| Net Debt Change | $17.9B | $104M |
| Other Financing & FX | $167M | $271M |
| Net Cash Increase | $271M | $271M |
- Operating Cash Flow$9.46B
- Capital Expenditure-$2.09B
- Free Cash Flow$7.38B
- Acquisitions-$19.9B
- Other Investing-$287M
- Share Buybacks-$793M
- Dividends Paid-$4.19B
- Net Debt Change$17.9B
- Other Financing & FX$167M
- Net Cash Increase$271M
Want to see what drove the FCF change?Free Cash Flow Bridge
Frequently asked questions
Data & methodology
Abbott Laboratories (ABT) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Forecast & Valuation
Operations
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement
Capital Return
- Buybacks0.44% TTM
- Dividend Profile2.47% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History9 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.